SOURCE: Novo Nordisk A/S

September 15, 2008 08:59 ET

Novo Nordisk A/S -- Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - September 15, 2008) - Novo Nordisk A/S - Share repurchase programme


On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 1.7 billion in the period from 15 August 2008 to 19 December 2008.

Since the announcement as of 8 September 2008, the following transactions have been made under the programme:

                  Number of    Average     Transaction
                   shares   purchase price value, DKK
Accumulated, last
announcement       850,000                 249,283,476
08 September 2008  50,000      278.2200    13,911,000
09 September 2008  65,000      278.2500    18,086,250
10 September 2008  90,000      278.2950    25,046,550
11 September 2008  50,000      271.3650    13,568,250
12 September 2008  50,000      273.6200    13,681,000
Accumulated under
the programme     1,155,000                333,576,526

With the transactions stated above, Novo Nordisk owns a total of 22,367,960 treasury shares, corresponding to 3.5% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,300 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Further information:

Media:                 Investors:

Elin K Hansen          Mads Veggerby Lausten
Tel: (+45) 4442 3450   Tel: (+45) 4443 7919
ekh@novonordisk.com    mlau@novonordisk.com

                       Hans Rommer
                       Tel: (+45) 4442 4765
                       hrmm@novonordisk.com

In North America:
Sean Clements
Tel: (+1) 609 514 8316
secl@novonordisk.com

Company Announcement no 59 / 2008





Copyright © Hugin AS 2008. All rights reserved.

Contact Information